More recently, an agent which targets both GLP-1 and GIP receptors (tirzepatide) received regulatory clearance for treatment of type 2 diabetes
Other important safety information Do not use B12/MIC if you are currently pregnant, breastfeeding, or plan to become pregnant or breastfeed
This patient experienced significant improvement with subcutaneous injections of 1.8 mg daily of liraglutide, resulting in nearly complete resolution of HHD manifestations in the neck, armpits, and inguinal and abdominal folds [42]
Use effective contraception while taking this medication
While the medication doesnt fix the underlying emotional issues, the reduction in overall appetite and the diminished appeal of highly rewarding foods create a buffer
Light physical activity like walking for 15 to 20 minutes after meals can help with digestion and blood sugar management